Abstract
A man with acute lymphoblastic leukaemia developed disseminated Scedosporium prolificans infection following chemotherapy for disease relapse while on posaconazole prophylaxis. Scedosporium prolificans infection during posaconazole prophylaxis has not been reported previously. This report is timely as the uptake of posaconazole, the broadest spectrum azole clinically available, is likely to grow with recent evidence supporting its role as prophylaxis against invasive fungal infections in high-risk haematology patients.
Original language | English |
---|---|
Pages (from-to) | 83-86 |
Number of pages | 4 |
Journal | Mycopathologia |
Volume | 166 |
Issue number | 2 |
DOIs | |
Publication status | Published - 1 Aug 2008 |
Externally published | Yes |
Keywords
- Acute leukaemia
- Posaconazole
- Scedosporium prolificans